Blue Fin Capital, Inc. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 232 filers reported holding PDL BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
Blue Fin Capital, Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2015$138,000
-21.6%
27,3710.0%0.11%
-15.7%
Q2 2015$176,000
-40.1%
27,371
-34.6%
0.13%
-40.1%
Q1 2015$294,000
-15.0%
41,821
-6.7%
0.21%
-18.8%
Q4 2014$346,000
-2.3%
44,821
-5.4%
0.26%
-7.1%
Q3 2014$354,000
-21.2%
47,391
+2.2%
0.28%
-21.9%
Q2 2014$449,000
+129.1%
46,361
+96.8%
0.36%
+108.1%
Q1 2014$196,000
+1.0%
23,556
+2.5%
0.17%0.0%
Q4 2013$194,00022,9710.17%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2014
NameSharesValueWeighting ↓
SMH CAPITAL ADVISORS INC 81,713$176,0000.39%
BRANDES INVESTMENT PARTNERS, LP 5,465,156$11,805,0000.30%
Crestline Management, LP 875,000$1,890,0000.30%
West Family Investments, Inc. 539,450$1,165,0000.29%
WEBER ALAN W 200,000$432,000,0000.19%
Zebra Capital Management LLC 73,910$160,0000.18%
RBF Capital, LLC 569,323$1,230,0000.14%
Leap Investments LP 69,496$150,0000.08%
Connor, Clark & Lunn Investment Management Ltd. 4,387,038$9,476,0000.06%
CHICAGO EQUITY PARTNERS LLC 519,315$1,122,0000.05%
View complete list of PDL BIOPHARMA INC shareholders